Lipid profile alterations in non-infectious uveitis: correlation with quantitative optical coherence tomography angiography parametersJunhui Shen, Guangming Qin, Lei Feng
15 May 2024
Bibliometric analysis of the uveitis literature and research trends over the past two decadesTingxiao Gao, Hayley Monson, Tina Felfeli
15 September 2023
Occurrence of uveitis in a population-based cohort of inflammatory bowel diseases followed for 10 years: an observational studyElisabet Granstam, Anders Rönnblom
14 July 2023
Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitisOliver Mase, Mustafa Qasem, Nicholas Beare
14 June 2023
Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR CongoNadine Nsiangani Lusambo, Dieudonné Kaimbo Wa Kaimbo, Dieudonné Mumba Ngoyi, Pierre Akilimali Zalagile, Alejandra de-la-Torre
20 January 2023
Colombian ocular inflammatory diseases epidemiology study (COIDES): prevalence, incidence and sociodemographic characterisation of Scleritis in Colombia, 2015–2020Carlos Cifuentes-González, William Rojas-Carabali, Germán Mejia-Salgado, Juan Sebastián Pineda-Sierra, Paula Tatiana Muñoz-Vargas, Laura Boada-Robayo, Danna Lesley Cruz, Alejandra de-la-Torre
14 November 2022
Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer’s perspectiveSeenu M Hariprasad, George Joseph, Patrick Gagnon-Sanschagrin, Elizabeth Serra, Subrata Bhattacharyya, Jérôme Bédard, Annie Guérin, Thomas Arno Albini
10 November 2021
Adalimumab in patients with vision-threatening uveitis: real-world clinical experienceTimothy Lee Tang Lee Say, Verlyn Yang, Jacob M Fingret, Sophia Zagora, Richard Symes, Christine Younan, Elisa Eleanor Cornish, Nitin Verma, Anthony Sammel, Denis Wakefield, Deborah Speden, Peter J McCluskey
27 September 2021